ArticlePLOS global public health2025
Implementation of an Integrated Sample Referral System (ISRS) in Ghana: Successes and Lessons Learnt from a Pilot Study in the Northern and Greater Accra Regions.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation of Multi-Stakeholder Perspectives on the Preparedness of Ghana's Animal Health Services for African Swine Fever Control: A Cross-Sectional Study.Health science reports · 2026Article
- National Implementation of a Tuberculosis Sample Referral Network to Expand Access to Molecular Diagnosis in the Republic of Congo: Pilot Evaluation and Programmatic Analysis (2023-2025).Tropical medicine and infectious disease · 2026Article
- Lungs Are Only Half the Story: Programmatic Shifts to Prioritize Pediatric Extrapulmonary Tuberculosis Detection in High-Burden Settings.Journal of the Pediatric Infectious Diseases Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The outbreak of the COVID-19 pandemic exposed the fragile health system in Ghana and in particular, its specimen referral system (SRS), which for years had been limited to Tuberculosis (TB), HIV Viral Load and Early Infant Diagnosis among few laboratories. The implementation of a siloed SRS with the sole focus on TB, HIV viral load, and early infant diagnosis has been to the detriment of other diseases of public health importance. This programmatic activity aimed to assess the feasibility of an integrated specimen referral system (ISRS) in Ghana's Greater Accra and Northern Regions. Between January and November 2022, we established and piloted an ISRS through extensive stakeholder engagements using the hub and spoke model. As part of the intervention package, capacity building workshops, logistics support and transportation were provided to all program facilities. Standard paper-based log books and interviews were employed to collect data from 105 health facilities (84 in Greater Accra and 21 in Northern Region) to evaluate the ISRS's successes, challenges, and develop future scale-up recommendations. Overall, 4,239 samples ranging from suspected cases of measles, monkeypox, COVID-19, yellow fever (YF), acute flaccid paralysis, TB, Buruli ulcer, HIV viral load (VL), early infant diagnosis (EID), and meningitis were transported during the program period. The turnaround time (TAT) varied across diseases: 1-2 days for TB/COVID-19, 5-7 days for YF, 7-14 days for influenza, and 14 days - 3 months for VL/EID cases. The quality of specimens referred improved, with only 2 samples rejected during the pilot. Qualitative analysis uncovered improvements in ISRS efficiency including, sample delivery, TAT, documentation, coordination and logistics, monitoring and tracking, sample quality, and record-keeping. This preliminary programmatic activity provides evidence of the feasibility of creating a nationwide ISRS to facilitate the quick detection and management of all diseases of public health importance in Ghana.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.